13
Forecasting: Managing the future with dynamic patient flow models

Patient flow enabled forecasting for market access, marketing and finance

Embed Size (px)

Citation preview

Page 1: Patient flow enabled forecasting for market access, marketing and finance

Forecasting:Managing the future with

dynamic patient flow models

Page 2: Patient flow enabled forecasting for market access, marketing and finance

05/03/2023© 2016 IM Associates: Dynamic Patient Flow Model

2

Patient flow dynamics help making the most of the product life cycle.

Business developmentEvaluate the potential

of a product in a market

Market AccessReinforce the health economics file with patients simulations.

Pre-marketingPlan commercial

resources based on potential sales.

LaunchEvaluate sales targets.

Manage stock planning.

GrowRe-evaluate the

strategy by understanding drivers

LOEIdentifying the drivers which will reinforce

carry-over.

Page 3: Patient flow enabled forecasting for market access, marketing and finance

05/03/2023© 2016 IM Associates: Dynamic Patient Flow Model

3

Support important decisions reg. business development:- Research;- Product acquisition;- Licensing,…

In today’s pharma business, forecasting has never been so critical.

Understand the strategic importance of the patient flow: - Diagnostic rate;- Compliance;- Treatment duration;- …

Understand new markets / new indications with less data.

Better target your resources & promotional investment:- FF size;- Investmentin awareness, compliance, …

Managing uncertainties in the future:- Outcomes of clinical studies;- Decisions on reimbursement;- Healthcare reform.

Forecasting brings more than financial forecasts. It generates critical strategic value as it provides answers to following needs:

Page 4: Patient flow enabled forecasting for market access, marketing and finance

05/03/2023© 2016 IM Associates: Dynamic Patient Flow Model

4

An essential tool in Market Access.

External Price Negotiations

Simulations of impact on public budget.

Business Development

Targets; Market dynamics; Impact actions

Internal Price Submission

Simulations of impact on sales

Dynamic Patient Flow Model

Page 5: Patient flow enabled forecasting for market access, marketing and finance

© 2016 IM Associates: Dynamic Patient Flow Model5

Patient-based forecasting as a complementary tool to in-house forecasting tools.

05/03/2023

In-house forecasting tool(Mostly based on high level market trends)

Dynamic patient flow model

t

Sales (€)

Based on assumptions of high level market trends (Total size of sub-markets; evolution of competition; market growth)

1° lineP.1

P.2

P.3

2° line

P.A

P.B

P.C

Based on numbers inherent to patient flow (incidence, prevalence, switch rate, compliance,…)

Offers grounded

assumptions

Cross-checks outcomes

Translates in # patients

Page 6: Patient flow enabled forecasting for market access, marketing and finance

05/03/2023© 2016 IM Associates: Dynamic Patient Flow Model

6

Patient Flow Empowered Forecasting

IM Associates’ approach to forecast is based on a tool simulating patient flows month-by-month. It is a fully transparent and flexible methodology generating real eye-openers on your sales dynamics. This time-saving solution helps getting internal alignment on forecasts and supporting decisions on commercial and market access strategies.

Page 7: Patient flow enabled forecasting for market access, marketing and finance

05/03/2023© 2016 IM Associates: Dynamic Patient Flow Model

7

What is patient flow dynamic?

Diagnosed patients

Flow dynamics provides a simple and flexible model to understand the patient journey and measures the number of patients:• at any moment of time• at any step of the flow

Popu-lation

Patients on product A

Patients on product B

New patients

Incidence rate

Diagnostic rate

New patient share

1.000 / month 80%

% Switch

% drop-out

% drop-out

% Switch

6 months

4 months

Patient flow (Simplified example)

Page 8: Patient flow enabled forecasting for market access, marketing and finance

05/03/2023© 2016 IM Associates: Dynamic Patient Flow Model

8

In a standard patient flow approach, we first calculate the number of patients on treatment. Then number of patients are converted into number of boxes and in sales.

Patients on product X

Volume forecast

Sales forecast

Patient share

Switch rate

Drop-out rate

Compliance

Posology (Units/month)

Price

Conversion

Patients on product

Population Potentialpatients

Patients on treatment

Population growth

Age / Gender

Prevalence

Incidence

Diagnostic rate

Treatment choice

Patients on treatment

Page 9: Patient flow enabled forecasting for market access, marketing and finance

05/03/2023© 2016 IM Associates: Dynamic Patient Flow Model

9

This approach enables analysing the consolidated impacts of price and volume on the final sales.

2016: steep growth of patient, which is not

sufficient to compensate the price decrease

2017 and beyond: Thanks to its price decrease, BrandX lowers the patient loss to

generics.

Business case

Page 10: Patient flow enabled forecasting for market access, marketing and finance

05/03/2023© 2016 IM Associates: Dynamic Patient Flow Model

10

Scenarios help evaluating the sales impact of decisions, and the time when the impact occurs.

Patients versus base case

2014 6.674 6.674 0 0%2015 6.834 6.834 0 0%2016 7.051 7.051 0 0%2017 6.894 6.664 -230 -3%2018 6.709 6.224 -485 -8%2019 6.558 5.865 -693 -12%

Sales versus base case

Fiscal Year Base case SalesDelta

vs. base case% vs.

base case2014 26.768.532 26.768.532 0 0%2015 27.097.257 27.097.257 0 0%2016 25.874.012 25.874.012 0 0%2017 24.762.869 25.646.640 883.771 3%2018 23.962.230 23.931.913 -30.317 0%2019 23.363.991 22.446.978 -917.014 -4%

2017 - 2019 72.089.091 72.025.531 -63.560 0%

No price decrease

2017: In the short term, the decision to maintain the price is beneficial (compared to scenario with price decrease).But the sales impact becomes negative in 2019, as the decrease in patients annihilates the extra sales due to higher price.

Business case

Base case scenario

No price decrease

Scenario 1

Price decrease

Page 11: Patient flow enabled forecasting for market access, marketing and finance

05/03/2023© 2016 IM Associates: Dynamic Patient Flow Model

11

IM Associates helps searching data to support the assumptions related to prevalence, incidence, diagnostic rate, switch & drop-out, etc…

Existing market research(Primary data)

Additional surveyDesk research(Secondary data)

We analyze your primary data to extract the relevant evidence.

Based on our knowledge, we search and analyze available data-sources, or provide recommendations in terms of 3rd party data.

When needed, we conduct additional survey through online questionnaires, telephone survey or advisory boards.

Page 12: Patient flow enabled forecasting for market access, marketing and finance

05/03/2023© 2016 IM Associates: Dynamic Patient Flow Model

12

IM Associates’ approach is transparent, flexible and powerful.

TransparentThe assumptions and their impact are easy to understand.Future sales are clearly split in existing/new/switched patients.

FlexibleParameters (launch data; treatment duration; compliance; switch rate;…) are modifiable and the impact on outcomes is immediately simulated.

PowerfulAble to model simple or complex patients flows.

Our approach Your benefits

You save time, as complex patient journey can be easily modeled.

You gain insight on the patient flow and the drivers influencing your sales (switch rate; compliance; duration of treatment;…).

You reach internal alignment on forecasts by discussing clearly defined parameters.

You manage future uncertainties by analyzing multiple scenarios and by refreshing the forecasting with the latest available data.

You get reliable forecast. This helps you setting the right marketing investment and SMART targets for your sales teams.

Page 13: Patient flow enabled forecasting for market access, marketing and finance

Jurgen De BaerdemaekerCEO

[email protected]

Mob.: + 32 477 70 94 41

IM Associates assures effective decisions are taken in the complex healthcare environment.